PTH and hypercalcemia disease: Patients with FHH are heterozygous for the CaR mutation and have a normal or mildly increased circulating parathyroid hormone (PTH) level, normal parathyroid histology or mild parathyroid hyperplasia, and mild to moderate hypercalcemia [2], [3].